• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNTHES GMBH UNK - RESORBABLE IMPLANTS: MESH; SURGICAL MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNTHES GMBH UNK - RESORBABLE IMPLANTS: MESH; SURGICAL MESH Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Post Operative Wound Infection (2446)
Event Type  Injury  
Manufacturer Narrative
510k: this report is for an unk - resorbable implants: mesh/unknown lot.Part and lot numbers are unknown; udi number is unknown.Complainant part is not expected to be returned for manufacturer review/investigation.Without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
This report is being filed after the review of the following journal article: jung j.S., kang d.H., lim n.K., kim h., (2020)orbital wall restoration with primary bone fragments in complex orbital fractures: a preliminary study, arch craniofac surg vol.21 no.3, 156-160 (korea, south) https://doi.Org/10.7181/acfs.2020.00101.This study aims to evaluate 23 patients who underwent complex orbital wall restoration using primary bone fragments with an uneventful postoperative course and favorable outcomes.Between 2012 and 2019, 23 patients (21 males, 2 females) with complex orbital wall fractures who were treated with the standard open reduction method using the transnasal and transorbital approaches were included in the study.Bony restoration was done by placing a porous polyethylene implant such as synpor (synthes inc., west chester, pa, usa) or medpor (porex surgical inc., newnan, ga, usa) or a resorbable mesh plate such as rapidsorb (synthes inc.) to bridge the remaining defect.Follow-up was performed 6 months after treatment.The following complications were reported as follows: short term complications included soft-tissue infections in two patients.This report is for an unknown synthes porous polyethylene implant synpor and unknown synthes resorbable mesh plate rapidsorb.This report is for one (1) unk - resorbable implants: mesh.This is report 2 of 3 for (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK - RESORBABLE IMPLANTS: MESH
Type of Device
SURGICAL MESH
Manufacturer (Section D)
SYNTHES GMBH
eimattstrasse 3
oberdorf 4436
SZ  4436
Manufacturer Contact
kara ditty-bovard
1302 wright lane east
west chester, PA 19380
6107195000
MDR Report Key11599858
MDR Text Key243342308
Report Number8030965-2021-02481
Device Sequence Number1
Product Code EZX
Combination Product (y/n)N
Reporter Country CodeKS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 03/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/05/2021
Initial Date FDA Received03/31/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-